Viking Global Investors
ZNTL icon

Viking Global Investors’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Viking Global Investors’s Portfolio ZNTL Stock Details ZNTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,026,656
Closed -$56.9M – 101
2022
Q2 		$56.9M Hold
2,026,656
– – 0.26% 65
2022
Q1 		$93.5M Sell
2,026,656
-91,628
-4% -$4.94M 0.38% 64
2021
Q4 		$178M Hold
2,118,284
– – 0.51% 55
2021
Q3 		$141M Sell
2,118,284
-281,000
-12% -$16.2M 0.39% 63
2021
Q2 		$128M Hold
2,399,284
– – 0.39% 59
2021
Q1 		$104M Sell
2,399,284
-612,000
-20% -$26.3M 0.31% 66
2020
Q4 		$156M Sell
3,011,284
-1,432,000
-32% -$64.6M 0.43% 58
2020
Q3 		$145M Hold
4,443,284
– – 0.52% 50
2020
Q2 		$213M Buy
+4,443,284
New +$170M 0.92% 36

Other funds holding ZNTL

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return